Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice


Bagci R., ŞAHİNTÜRK V. , ŞAHİN E.

TISSUE & CELL, vol.59, pp.62-69, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 59
  • Publication Date: 2019
  • Doi Number: 10.1016/j.tice.2019.07.001
  • Title of Journal : TISSUE & CELL
  • Page Numbers: pp.62-69
  • Keywords: Azoramide, Endoplasmic reticulum stress, GRP78, Insulin resistance, Nonalcoholic fatty liver disease, Steatosis, ER STRESS, INSULIN-RESISTANCE, MODEL, HOMEOSTASIS, GLUCOSE

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a frequent health problem. The insulin resistance and endoplasmic reticulum (ER) stress have been suggested to play important roles in the development and progression of NAFLD. However these processes and correlations have not fully been understood yet. Azoramide, an antidiabetic drug, has the potential for reducing insulin resistance and ER stress in obese mice. To date, there is no study on the effects of azoramide in NAFLD. The aim of this study was to investigate the potential role of azoramide on insulin resistance and ER stress in NAFLD induced mice.